New Jersey A 1636: Classifies 7 Hydroxymitragynine as Schedule I drug and bans sale of products containing substance.

Status: Introduced, Referred to Assembly Consumer Affairs Committee (as of 2026-01-13)

State: New Jersey · Session: 222 · Bill: A 1636

Sponsors: Kean, Sean T.

View New Jersey A 1636 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.